Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
401 participants
OBSERVATIONAL
2022-03-01
2023-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This association is frequently underestimated with regard to the difficulty of clinical diagnosis.
The investigators expect that the application of the inferior vena cava collapsibility index (ΔIVC)could be useful in this issue.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Congestive Heart Failure
NCT01885403
Assessment of The Clinical Course of Dyspnea in Acute Heart Failure Patients
NCT01615926
Acute Heart Failure - COngestion Discharge Evaluation
NCT04332692
Congestion and LActate at diScHarge in Acute Heart Failure
NCT07345156
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation
NCT04343443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AHF-group
patients with AECOPD and acute heart failure
calculation of the inferior vena cava collapsibility index
the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure
non AHF-group
patients with AECOPD without acute heart failure
calculation of the inferior vena cava collapsibility index
the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
calculation of the inferior vena cava collapsibility index
the ΔIVC was calculated by the emergency physician who was blinded from the patient's medical history using the formula ((IVCmax-IVCmin)/IVCmax) X100.A cutoff of 15% was used to define the presence(\<15%) or absence(\>15%) of heart failure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* post traumatic dyspnea
* instable hemodynamic or neurological status
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Monastir
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pr. Semir Nouira
professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nouira Semir, Professor
Role: PRINCIPAL_INVESTIGATOR
University of Monastir
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Fattouma Bourguiba
Monastir, , Tunisia
Emergency Departement
Monastir, , Tunisia
Emergency department of fattouma bourguiba university hospital
Monastir, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ΔIVC /AHF/ AECOPD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.